To establish rules to encourage and facilitate the participation of transgender runners at WSER with the goal of ensuring fair and inclusive practices that respect the personal rights and dignity of transgender entrants while preserving the integrity of competition for awards and records based on sex.
A male-to-female transgender entrant can register to compete as a female provided the runner has been undergoing continuous, medically supervised hormone treatment for gender transition for at least one year prior to the race.
A female-to-male transgender entrant can register to compete as a male with no restrictions. The only exception is female-to-male transgender runners can no longer register to compete as a female if they have begun hormone treatment related to their gender transition that includes testosterone or any other banned substance.
A runner’s self-declared gender at registration will be accepted at face value. The sole reason for this policy is to ensure fairness regarding competition for awards and records. Therefore, there shall be no basis for, or tolerance of, any challenge to a runner’s self-declared gender unless a top 10 finish or age group award is at stake.
WSER shall have the sole authority to review any challenge regarding the gender status of a top 10 finisher or age group winner. Any such challenge must be made directly in person or writing to the Race Director with the utmost discretion and respect for the privacy of all parties involved. WSER in its sole discretion will determine whether there is a legitimate basis for the challenge.
Gender Status Review
In the event of a challenge, WSER may ask the runner for documentation from a medical doctor or healthcare provider or other qualified professional certifying that the entrant has undergone continuous, medically supervised hormone treatment for gender transition for at least one year prior to the race. (See WSER Medical Clearance.) Transgender entrants, at their option, may provide the medical documentation related to their gender transition to the Race Director prior to the race. All information about the runner’s gender identity and medical information, including any information provided pursuant to this policy, shall be kept strictly confidential.
The final decision regarding the entrant’s gender status for registration purposes shall be within the sole discretion of WSER. If it is determined that the runner is not in compliance with WSER’s rules for transgender entrants, the runner will be allowed to keep their WSER finisher’s buckle but any top 10 finisher or age group awards shall be returned to WSER. WSER will attempt to protect the runner’s privacy interests to the maximum extent possible.
WSER Drug Test Program
If a transgender runner is selected for drug testing at WSER and tests positive for a banned substance, it will be considered a legitimate medical use under WSER’s Drug Testing Policy and Protocols if the runner can demonstrate that the banned substance was being taken in connection with the person’s medically supervised hormone treatment for gender transition. The only exception is female-to-male transgender entrants who register to compete as a female.